Status | Study |
Completed |
Study Name: Laboratory Diagnosis and Prognosis of Severe Dengue Condition: Dengue Fever Date: 2011-08-22 |
Completed |
Study Name: Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers Condition: Dengue Dengue Hemorrhagic Fever Date: 2011-08-03 Interventions: Biological: Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 vir |
Active, not recruiting |
Study Name: Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia Condition: Dengue Dengue Fever Dengue Hemorrhag Date: 2011-06-08 Interventions: Biological: Live, attenuated, dengue serotype 1, 2, 3, 4 virus |
Completed |
Study Name: Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia Condition: Dengue Fever Dengue Hemorrhagic Fever Date: 2010-12-03 Interventions: Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 vi |
Completed |
Study Name: Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America Condition: Dengue Dengue Hemorrhagic Fever Date: 2010-08-20 Interventions: Biological: Live, attenuated, recombinant dengue serotype 1 , 2, 3 , and 4 v |
Completed |
Study Name: Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia Condition: Dengue Fever Dengue Hemorrhagic Fever Date: 2010-05-27 Interventions: Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, & 4 |
Completed |
Study Name: A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines Condition: Dengue Fever Dengue Hemorrhagic Fever Date: 2010-02-05 Interventions: Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 vir |
Completed |
Study Name: Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus Condition: Dengue Shock Syndrome Dengue Hemorrhagic Fever Date: 2009-06-11 Interventions: Biological: DEN4 Vaccine Candidate |
Completed |
Study Name: Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US Condition: Dengue Fever Dengue Hemorrhagic Fever Date: 2008-02-06 Interventions: Biological: ChimeriVax™ Tetravalent Dengue Vaccine |
Completed |
Study Name: Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus Condition: Dengue Hemorrhagic Fever Date: 2007-04-06 Interventions: Biological: rDEN1delta30 Live |